Global Lifestyle Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Inquire for discount at http:// www. reportsnreports. com / contacts / discount. aspx? name = 917357
Further, the report states that one challenge in the market is the patent expiries. The market is currently dominated by key drugs, namely Cymbalta by Eli Lilly, Abilify by Bristol Myers Squibb( BMS), Cialis( tadalafil) by Eli Lilly, Staxyn / Levitra( vardenafil) by Bayer, and Viagra( sildenafil citrate) by Pfizer. The depression drugs such as Cymbalta witnessed a patent expiry in 2013. Due to the patent expiry, Cymbalta reported a YoY decline of 36.36 % in 2015. Also, Abilify reported a YoY decline of 63.07 % in 2015 due to patent expiration in the US and EU. In addition, the erectile dysfunction drugs Viagra( approved in 1998), Cialis( approved in 2003), Staxyn / Levitra( approved in 2003) drugs were approved long back, and their patents are nearing expiration in the next few years.
About Us:
ReportsnReports. com is your single source for all market research needs. Our database includes 500,000 + market research reports from over 100 + leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.